These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects. Tsutsui H; Araki H; Nagata Y; Nakamura M Clin Ther; 1984; 6(6):770-7. PubMed ID: 6509460 [TBL] [Abstract][Full Text] [Related]
25. [Proceedings: Effect of aprindine on extrasystole and hemodynamics in an exertion study]. Niederberger M; Gasic S; Haber P Z Kardiol; 1975; Suppl 2():85. PubMed ID: 53953 [No Abstract] [Full Text] [Related]
26. Aprindine treatment of recurrent ventricular tachycardia in patients with mitral valve prolapse. Troup PJ; Zipes DP Am Heart J; 1979 Mar; 97(3):322-8. PubMed ID: 420071 [No Abstract] [Full Text] [Related]
27. A case of left atrial automatic tachycardia successfully treated with aprindine. Kuriyama M; Nagamoto Y; Nakata K; Hayakawa T; Kuroiwa A J UOEH; 1988 Dec; 10(4):417-22. PubMed ID: 3212299 [TBL] [Abstract][Full Text] [Related]
28. [Ventricular heart-rhythm disorders - sudden cardiac death: results of long-term drug therapy]. Lüderitz B; Manz M; Steinbeck G Verh Dtsch Ges Herz Kreislaufforsch; 1983; 49():209-17. PubMed ID: 6666303 [No Abstract] [Full Text] [Related]
29. [Effects of intravenous aprindine on hemodynamics in patients with cardiac dysfunction and its pharmacodynamics in patients with premature ventricular contractions]. Matsumoto N; Hayasaki K Kokyu To Junkan; 1990 Apr; 38(4):383-9. PubMed ID: 1694595 [TBL] [Abstract][Full Text] [Related]
30. [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders]. Leclercq JF; Attuel P; Milosevic D; Rosengarten MD; Coumel P Arch Mal Coeur Vaiss; 1981 Aug; 74(8):923-30. PubMed ID: 6793009 [TBL] [Abstract][Full Text] [Related]
31. Study of moxaprindine with programmed electrical stimulation of the heart in patients with reentrant tachyarrhythmias. Waleffe A; Mary-Rabine L; Kulbertus HE Am J Cardiol; 1980 Mar; 45(3):640-7. PubMed ID: 7355761 [No Abstract] [Full Text] [Related]
33. [Agranulocytosis after use of aprindine (Fiboran)]. Poortermans JC; Majid PA; Roos JP Ned Tijdschr Geneeskd; 1976 Nov; 120(46):2011-2. PubMed ID: 1012364 [No Abstract] [Full Text] [Related]
34. Aprindine psychosis. Jacobs GP; Pores IH Am Heart J; 1980 Sep; 100(3):347-8. PubMed ID: 7405806 [TBL] [Abstract][Full Text] [Related]
35. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy]. Hausamen TU; Weber FW Dtsch Med Wochenschr; 1977 Oct; 102(42):1523-4. PubMed ID: 913289 [No Abstract] [Full Text] [Related]
36. Aprindine-induced liver injury. Elewaut A; Van Durme JP; Goethals L; Kauffman JM; Mussche M; Elinck W; Roels H; Bogaert M; Barbier F Acta Gastroenterol Belg; 1977; 40(5-6):236-43. PubMed ID: 920044 [No Abstract] [Full Text] [Related]
37. Effect of 2 anti-arrhythmic drugs aprindine and moxaprindine on the replication capacity of murine and human haemopoietic cells. Stryckmans PA; Ronge-Collard E; Delforge A; Lambert M; Suciu S Scand J Haematol; 1982 Oct; 29(4):331-7. PubMed ID: 7178839 [TBL] [Abstract][Full Text] [Related]
38. Effective plasma concentrations of aprindine in canine ventricular arrhythmias. Hashimoto K; Komori S; Ishii M; Kamiya J J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593 [TBL] [Abstract][Full Text] [Related]